Foster Dykema Cabot & Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5K Hold
288
﹤0.01% 229
2025
Q4
$23.6K Hold
288
﹤0.01% 234
2025
Q3
$21.6K Hold
288
﹤0.01% 297
2025
Q2
$21.3K Hold
288
﹤0.01% 247
2025
Q1
$23.2K Hold
288
﹤0.01% 237
2024
Q4
$22.5K Sell
288
-171
-37% -$14.5K ﹤0.01% 254
2024
Q3
$43.1K Buy
459
+171
+59% +$14.4K ﹤0.01% 233
2024
Q2
$22.4K Hold
288
﹤0.01% 220
2024
Q1
$26.2K Sell
288
-50
-15% -$4.16K ﹤0.01% 213
2023
Q4
$26.1K Buy
+338
New +$23.7K ﹤0.01% 182

Other funds holding GEHC

Foster Dykema Cabot & Partners's GEHC Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its GE HealthCare (GEHC) position steady in Q1 2026 at 288 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

Foster Dykema Cabot & Partners first reported a position in GEHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $43.1K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Foster Dykema Cabot & Partners held 288 shares of GE HealthCare worth $20.5K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its GE HealthCare share count unchanged in Q1 2026.
  • GE HealthCare made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #229 holding.
  • Foster Dykema Cabot & Partners first reported a position in GE HealthCare in Q4 2023 and has held it in 10 quarters since.
  • Foster Dykema Cabot & Partners's GE HealthCare position peaked at $43.1K in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.